Literatur
Raffaghello L et al. Proc Natl Acad Sci U S A. 2008;105(24):8215–20.
Lee C et al. Cancer Res. 2010;70(4):1564–72.
Lee C et al. Sci Transl Med. 2012;4(124):124ra27.
Huisman SA et al. Cell Cycle. 2015;14(14):2333–9.
Huisman SA et al. Br J Pharmacol. 2016;173(5):804–14.
Safdie F et al. PLoS One. 2012;7(9):e44603.
D’Aronzo M et al. Oncotarget. 2015;6(21):18545–57.
Lee C, Longo VD. Oncogene. 2011;30(30):3305–16.
Safdie FM et al. Aging (Albany NY). 2009;1(12):988–1007.
Klement RJ, Fink MK. Oncogenesis. 2016;5:e193.
Cheng CW et al. Cell Stem Cell. 2014;14(6):810–23.
Klement RJ, Champ CE. Cancer Metastasis Rev. 2014;33(1):217–29.
Klement RJ. Oncologist. 2013;18(9):1056.
Originalie
de Groot S et al. The effects of short-term fasting on tolerance to (neo) adjuvant chemotherapy in HER2-negative breast cancer patients: a randomized pilot study. BMC Cancer. 2015;15:652.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Klement, R.J. Fasten als therapeutische Ergänzung. Info Onkol. 19, 14–16 (2016). https://doi.org/10.1007/s15004-016-5334-8
Published:
Issue Date:
DOI: https://doi.org/10.1007/s15004-016-5334-8